Tus-Guhan Group Corp Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tus-Guhan Group Corp Ltd with three other
companies in this sector in China:
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd
sales of 203.17 million Chinese Renmimbi [US$28.86 million]
of which 98%
was Chinese Herbal Medicine Trade),
Shenzhen Chipscreen Biosciences Co Ltd
(147.69 million Chinese Renmimbi [US$20.98 million]
Zhejiang Ausun Pharmaceutical Co Ltd
(243.89 million Chinese Renmimbi [US$34.65 million]
of which 32%
was Antibacterial Products).
Tus-Guhan Group Corp Ltd reported sales of 185.81 million Chinese Renmimbi (US$26.40 million)
December of 2018.
decrease of 45.9%
versus 2017, when the company's sales were 343.54 million Chinese Renmimbi.
Contributing to the drop in overall sales was the 40.1% decline
in Tcm and Tonics Manufacturing, from 275.51 million Chinese Renmimbi to 164.96 million Chinese Renmimbi.
However, these declines were partially offset by the increase in sales of
Western Medicine Manufacturing (up 18.4% to 19.88 million Chinese Renmimbi)
Others (up 61.0% to 966,568.40 Chinese Renmimbi)